These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17580963)

  • 1. Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates functional impairment of human apolipoprotein E.
    Tamamizu-Kato S; Wong JY; Jairam V; Uchida K; Raussens V; Kato H; Ruysschaert JM; Narayanaswami V
    Biochemistry; 2007 Jul; 46(28):8392-400. PubMed ID: 17580963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular Uptake and Clearance of Oxidatively-modified Apolipoprotein E3 by Cerebral Cortex Endothelial Cells.
    Cruz S; Narayanaswami V
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swapping the N- and C-terminal domains of human apolipoprotein E3 and AI reveals insights into their structure/activity relationship.
    Lek MT; Cruz S; Ibe NU; Beck WHJ; Bielicki JK; Weers PMM; Narayanaswami V
    PLoS One; 2017; 12(6):e0178346. PubMed ID: 28644829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.
    Tran TN; Kosaraju MG; Tamamizu-Kato S; Akintunde O; Zheng Y; Bielicki JK; Pinkerton K; Uchida K; Lee YY; Narayanaswami V
    Biochemistry; 2014 Jan; 53(2):361-75. PubMed ID: 24325674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semisynthesis and segmental isotope labeling of the apoE3 N-terminal domain using expressed protein ligation.
    Hauser PS; Raussens V; Yamamoto T; Abdullahi GE; Weers PM; Sykes BD; Ryan RO
    J Lipid Res; 2009 Aug; 50(8):1548-55. PubMed ID: 19098282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monomeric, biologically active, full-length human apolipoprotein E.
    Zhang Y; Vasudevan S; Sojitrawala R; Zhao W; Cui C; Xu C; Fan D; Newhouse Y; Balestra R; Jerome WG; Weisgraber K; Li Q; Wang J
    Biochemistry; 2007 Sep; 46(37):10722-32. PubMed ID: 17715945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of leucine zipper motif in apoE3 N-terminal domain lipid binding activity.
    Yamamoto T; Ryan RO
    Biochim Biophys Acta; 2006 Sep; 1761(9):1100-6. PubMed ID: 16945585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement of helix 1' enhances the lipid binding activity of apoE3 N-terminal domain.
    Redmond KA; Murphy C; Narayanaswami V; Kiss RS; Hauser P; Guigard E; Kay CM; Ryan RO
    FEBS J; 2006 Feb; 273(3):558-67. PubMed ID: 16420479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and biophysical characterization of recombinant rat apolipoprotein E: similarities to human apolipoprotein E3.
    Tran TN; Kim SH; Gallo C; Amaya M; Kyees J; Narayanaswami V
    Arch Biochem Biophys; 2013 Jan; 529(1):18-25. PubMed ID: 23103361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the lipid binding properties of the N-terminal domain of human apolipoprotein E3.
    Weers PM; Narayanaswami V; Ryan RO
    Eur J Biochem; 2001 Jul; 268(13):3728-35. PubMed ID: 11432739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E isoform-specific binding to the low-density lipoprotein receptor.
    Yamamoto T; Choi HW; Ryan RO
    Anal Biochem; 2008 Jan; 372(2):222-6. PubMed ID: 17923100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pyrene based fluorescence approach to study conformation of apolipoprotein E3 in macrophage-generated nascent high density lipoprotein.
    Kim SH; Kothari S; Patel AB; Bielicki JK; Narayanaswami V
    Biochem Biophys Res Commun; 2014 Jul; 450(1):124-8. PubMed ID: 24866239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Lipid Binding of Human Apolipoprotein E3 by Hydrogen/Deuterium Exchange/Mass Spectrometry and Fluorescence Polarization.
    Fabilane CS; Nguyen PN; Hernandez RV; Nirudodhi S; Duong M; Maier CS; Narayanaswami V
    Protein Pept Lett; 2016; 23(4):404-13. PubMed ID: 26902251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial overexpression, isotope enrichment, and NMR analysis of the N-terminal domain of human apolipoprotein E.
    Fisher CA; Wang J; Francis GA; Sykes BD; Kay CM; Ryan RO
    Biochem Cell Biol; 1997; 75(1):45-53. PubMed ID: 9192073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acrolein modifies apolipoprotein A-I in the human artery wall.
    Shao B; O'brien KD; McDonald TO; Fu X; Oram JF; Uchida K; Heinecke JW
    Ann N Y Acad Sci; 2005 Jun; 1043():396-403. PubMed ID: 16037261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.
    Veinbergs I; Van Uden E; Mallory M; Alford M; McGiffert C; DeTeresa R; Orlando R; Masliah E
    Exp Neurol; 2001 Jul; 170(1):15-26. PubMed ID: 11421580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anionic phospholipids inhibit apolipoprotein E--low-density lipoprotein receptor interactions.
    Yamamoto T; Ryan RO
    Biochem Biophys Res Commun; 2007 Mar; 354(3):820-4. PubMed ID: 17258176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the heparin binding sites in human apolipoprotein E.
    Saito H; Dhanasekaran P; Nguyen D; Baldwin F; Weisgraber KH; Wehrli S; Phillips MC; Lund-Katz S
    J Biol Chem; 2003 Apr; 278(17):14782-7. PubMed ID: 12588864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia.
    Georgiadou D; Chroni A; Vezeridis A; Zannis VI; Stratikos E
    PLoS One; 2011; 6(11):e27037. PubMed ID: 22069485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoform-specific modification of apolipoprotein E by 4-hydroxynonenal: protective role of apolipoprotein E3 against oxidative species.
    Abeer MI; Abdulhasan A; Haguar Z; Narayanaswami V
    FEBS J; 2023 Jun; 290(11):3006-3025. PubMed ID: 36661393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.